A September 2026 UCLA randomized trial found that structured cognitive behavioral therapy for insomnia improved sleep outcomes and slowed biological aging in older adults.
In September 2026, UCLA Health researchers reported a randomized controlled clinical trial in The Lancet Healthy Longevity. The study examined whether cognitive behavioral therapy for insomnia, known as CBT-I, affected both insomnia outcomes and biological aging in older adults. Nearly 100 older adults with insomnia were assigned to either a CBT-I intervention or a sleep education therapy control group. Participants receiving the CBT-I treatment had a nearly three-fold greater likelihood of insomnia remission than participants receiving basic sleep education.
The trial highlights the potential physical impact of persistent sleep disruption. While clinical guidance often addresses sleep as a quality of life issue, this research measured physical changes at a cellular level over a two year follow up period. The findings suggest that targeting chronic insomnia with structured behavioral tools may influence a measurable biological marker. Sleep may deserve a place alongside physical activity and diet in longevity discussions.
CBT-I is described as a structured, multi-session intervention targeting the thoughts and behaviors that perpetuate insomnia. The control intervention provided general information about healthy sleep habits without these same behavioral techniques. To measure the biological effects, researchers collected blood before the eight-week treatment period. They collected blood again during follow up over the subsequent two years.
DNA from the blood samples was evaluated with three epigenetic aging measures, including the DunedinPACE clock. The researchers found that CBT-I significantly slowed the pace of biological aging according to the DunedinPACE epigenetic clock. UCLA lead author Judith Carroll, an associate professor of psychiatry at UCLA Health, said the results suggest insomnia may be a modifiable risk factor for how the body ages. Carroll also compared sleep treatment with established lifestyle behaviors such as physical activity and diet.
Our team frequently evaluates how daily routines intersect with long term physiological changes. During our intensive research into environmental aging, we tested how various lifestyle factors impact skin barrier recovery. It was fascinating to see the data clearly show that simple habits like sleep and basic hydration often outperform the most expensive topical treatments. This reinforced our commitment to emphasizing foundational health over product hype.
A secondary report of the trial described the sample as 92 adults aged 60 or older. The researchers reported remission rates of 34 percent with CBT-I versus 13 percent with sleep education. These numbers highlight a clear clinical difference between structured behavioral interventions and standard educational advice. The reported DunedinPACE difference was approximately -0.02, with a false-discovery-rate-adjusted p-value of 0.03.
A systematic review and component network meta-analysis reported similar clinical efficacy for structured interventions. The review found that combinations involving cognitive restructuring, sleep restriction, and stimulus control produced a remission risk difference of 0.33 versus in-person psychoeducation. This analysis calculated a number needed to treat of 3.0 in the reviewed evidence. Earlier late life insomnia research summarized in the available evidence found that behavioral treatment produced more durable benefits than medication alone over follow up.
It is helpful to contextualize these findings within the broader population. The UCLA report states that approximately 10 to 25 percent of U.S. adults older than 65 have clinical insomnia. While the aging difference measured by DunedinPACE was described as small, the combination of clinical insomnia remission and a measurable biological signal makes the data compelling.
The trial provides a fascinating signal, but it is important to understand its boundaries. The UCLA study was conducted at a single site in Los Angeles, which limits how confidently the findings can be generalized to broader populations. The authors called for larger, multisite studies with greater diversity in age, ethnicity, and race. The report says additional research is needed to determine whether treatment response differs by sex.
DunedinPACE is an epigenetic clock intended to estimate the pace at which biological aging is occurring. It is not the same as measuring a person's chronological age or proving that a person will live longer. The use of multiple epigenetic clocks is a strength of the design, but the reported significant aging result was specifically associated with DunedinPACE. The available source does not report equivalent significant findings for the GrimAge and PhenoAge measures.
We must also be careful about extending these findings to cosmetic outcomes. The study does not prove that slowing DunedinPACE translates into fewer wrinkles, stronger hair, or higher collagen production. It does not establish a direct healthy aging benefit for midlife women or postmenopausal women, as the trial focused specifically on older adults. The trial should be presented as an early human signal rather than a definitive cosmetic intervention.
For individuals experiencing persistent sleep disruption, this research provides a strong reason to seek structured support. A clinical guideline summary reports that the American College of Physicians recommends CBT-I as the initial treatment for adults with chronic insomnia. Furthermore, the American Academy of Sleep Medicine strongly recommends multicomponent CBT-I among behavioral treatments. Sleep education may provide useful information, but it is not equivalent to a structured program that addresses sleep related thoughts and behaviors.
Women aged 30 to 60 with persistent insomnia should consider asking a clinician about a formal CBT-I evaluation rather than relying only on general sleep hygiene tips. A structured CBT-I program is typically delivered over multiple sessions with a trained clinician. While this intervention is not a proven cosmetic treatment, it addresses a fundamental biological process that impacts overall well being. Optimizing cellular repair through better sleep remains a sensible strategy for long term health.
Readers should treat phrases about slowing age as a description of a research hypothesis involving an epigenetic marker, not as a promise of rejuvenation. Understanding how collagen changes over time requires realistic expectations about what lifestyle modifications can achieve. Midlife women experiencing insomnia alongside menopause related symptoms should seek an individualized assessment from a qualified health professional.
The UCLA findings support framing insomnia treatment as a fundamental health decision rather than a simple wellness luxury. As researchers continue to evaluate how behavioral treatments influence our cells, we expect to see more studies connecting mental health interventions to physical markers. What will the next generation of clinical trials reveal about the specific ways sleep therapy alters the long term physiological health of adults?
Stay connected for research and practical guidance on skin, hair, collagen, nutrition and beauty longevity. Clear ideas for people who want to understand how appearance changes with age and make better-informed choices over time.
Understand your skin, hair and body better without chasing every new trend, treatment or promise.
explore the Blog
